TV
TriplePoint Ventures
Venture CapitalQuietTriplePoint Ventures is a venture capital firm that finances seed and early stage investments of life sciences and technology sectors.
4
Investments
1
Exits
—
AUM
25.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for TriplePoint Ventures.
Investment Thesis & Strategy
TriplePoint Ventures invests in seed and early-stage life sciences and technology companies. They focus on providing capital to promising ventures within these sectors.
Investment Activity
Deals per year over the last 8 years
1
20133
20141
20153
20162
20171
20180
20191
2020Portfolio Companies
Selected investments from their portfolio of 4 companies
C
Cerebral
Healthcare · Series A, 2020
C
Carbon Health
Healthcare · Series B, 2018
V
Vir Biotechnology
Biotech · Series A, 2017
T
Tempus
Healthcare · Series B, 2017
B
Bright Health
Healthcare · Series B, 2016
L
Lyra Health
Healthcare · Series B, 2016
P
Pear Therapeutics
Healthcare · Series B, 2016
L
Livongo
Healthcare · Series C+, 2015
C
Collective Health
Healthcare · Series B, 2014
M
Modern Meadow
Biotech · Series B, 2014
Z
Zymergen
Biotech · Series A, 2014
G
Guardant Health
Biotech · Series A, 2013
Frequently Asked Questions
TriplePoint Ventures focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Threshold
Menlo Park, United States · 841 deals
Lightspeed Venture Partners
Menlo Park, United States · 839 deals
Andreessen Horowitz
Menlo Park, United States · 826 deals
Khosla Ventures
Menlo Park, United States · 769 deals
Greylock
Menlo Park, United States · 720 deals
GGV Capital
Menlo Park, United States · 625 deals